Home > Analytics > CONCORD BIOTECH

CONCORD BIOTECH
Intrinsic Value | Fundamental Analysis

BOM : 543960     NSE : CONCORDBIO    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : NA
Jun 14,2024
Price(EOD): ₹ 1,530.95
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 16,013.74 Cr
Value of ₹ 1 Lac invested in CONCORD BIOTECH
on Aug 18,2023 (price: ₹ 941.85)

₹ 1 L

₹ 1.63 L

1W : 9.1% 1M : 10.5% 1Y : NA
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
Industry Peers & Returns1W1M1Y
CONCORD BIOTECH 9.1% 10.5% NA
SUN PHARMACEUTICAL INDUSTRIES 1.4% -0.7% 53.4%
CIPLA 2.9% 12.5% 59.5%
DR REDDYS LABORATORIES -0.7% 3.4% 29.5%
ZYDUS LIFESCIENCES -0.5% 2.6% 114.2%
DIVIS LABORATORIES 2% 16.7% 31.5%
MANKIND PHARMA 3.6% 7.3% 47.1%
TORRENT PHARMACEUTICALS 1.3% 7% 58.7%
LUPIN -2% -4.3% 96.3%

FUNDAMENTAL ANALYSIS OF CONCORD BIOTECH

 
Fundamentals Score
[ Q(TTM): Mar2024, Y: Mar2024
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]

Insights 💡 CONCORDBIO is one of the top 35% companies with good fundamentals ! Discover More →

VALUATION OF CONCORD BIOTECH

 
Valuation Score
[As on : Jun 14,2024 ]

Ratio Consolidated
P/E
P/B
P/S
52.56
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 304.73 Cr
[Latest Qtr - Mar2024 - Consolidated Results ]

10.49
P/B Calculated based on Book Value of Rs 1,526.65 Cr
[Latest Year - Mar2024 - Consolidated Results ]

15.75
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 1,016.94 Cr
[Latest Qtr - Mar2024 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 10% undervalued companies ! Discover More →

FAIR VALUE OF CONCORD BIOTECH

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
28463%
19502%
-

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF CONCORD BIOTECH


Insights 💡 CONCORDBIO is one of the top 42% companies with bullish price momentum currently! Discover More →

CONCORD BIOTECH vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF CONCORD BIOTECH

Year Debt/Equity ratio
Standalone Consolidated
2024
2023
2022
Avg_3yrs
0
0.02
0.05
0.02
0
0.02
0.05
0.02
[Last Annual Data : Mar2024]
Financial Ratios →

PLEDGED PROMOTER SHARES OF CONCORD BIOTECH

Pledged Promoter Shares
NA

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF CONCORD BIOTECH

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
32.46%
26.77%
30.81%
30.4%
17.02%
4.05%
4.22%
3.97%
QtrlyTrend
8
Latest Qtr: Mar2024
Quarterly Result Analysis →


CONCORD BIOTECH related INDICES

BSE Indices1W1M1Y
S&P BSE SMALL CAP 5% 10.1% 63.5%
S&P BSE MIDSMALLCAP 4.6% 9.7% 65.2%
S&P BSE IPO 3.8% 7.9% 63%
S&P BSE ALLCAP 2.6% 6.8% 41.1%
S&P BSE HEALTHCARE 1.5% 4.9% 53.5%
NSE Indices1W1M1Y
NIFTY MID SMALL400 4.3% 9.3% 63.1%
NIFTY SMALLCAP250 4.3% 9.4% 66.3%
NIFTY500 MULTICAP 50:25:25 3% 7.6% 48.1%
NIFTY 500 2.4% 6.7% 40.2%

You may also like the below Video Courses


FAQ about CONCORD BIOTECH


Is CONCORD BIOTECH good for long term investment?

As on Jun 14,2024, the Fundamentals of CONCORD BIOTECH look Strong and hence it may be good for long term investment! See Financial Performance of CONCORD BIOTECH . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is CONCORD BIOTECH UnderValued or OverValued?

As on Jun 14,2024, CONCORD BIOTECH is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of CONCORD BIOTECH ?

As on Jun 14,2024, the Intrinsic Value of CONCORD BIOTECH is Rs. 6.59 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 5.36
Fair Value [Median EV / Sales Model] : Rs. 7.81
Fair Value [Median Price / Sales Model] : Rs. 0.00
Estimated Median Fair Value of CONCORD BIOTECH : Rs. 6.59

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is CONCORD BIOTECH trading at a Premium or Discount?

As on Jun 14,2024, CONCORD BIOTECH is trading at a Premium of 23143% based on the estimates of Median Intrinsic Value!